February 20, 2006
Frank Pietrucha: (202) 543-6750; email@example.com
Claire Duggan: (202) 994-0616; firstname.lastname@example.org
Matt Lindsay: (202) 994-1423; email@example.com
NEW REPORT FINDS BRAZILIAN BIO-MEDICAL INDUSTRY IS ADVANCING THANKS TO REFORMS IN INNOVATION AND INTELLECTUAL PROPERTY SYSTEMS
GW Law Creative and Innovative Economy Center Presents Research at World Intellectual Property Organization's Development Agenda Meetings
WASHINGTON -- The newly launched Creative and Innovative Economy Center (CIEC) at The George Washington University Law School released a report today observing that "a quiet, little-noticed revolution" has been taking place in Brazil's bio-medical industry. The report was presented at a roundtable discussion in Geneva, Switzerland, for trade representatives from developing countries.
"The Brazilian government has been taking steps to promote technology commercialization by strengthening intellectual property rights, encouraging public-private research and development (R&D) projects, and providing venture capital to promising initiatives," noted report author Michael P. Ryan, director of the CIEC. "The fruits of these reforms have begun to ripen; these changes could lead the country toward technology commercialization leadership among developing countries in the years to come."
Trade representatives participated in today's discussion in between sessions at the World Intellectual Property Organization's (WIPO) Development Agenda meetings. The delegates, mostly from emerging growth nations, expressed interest in the CIEC report since Brazil has openly challenged trade policies enacted by WIPO over the past decade.
Recalling a recent trip to Brazil, Ryan said, "I'm impressed by the innovation progress I observed." He added that in June 2005, a Brazilian drug company named Ache released the country's first innovative pharmaceutical product, an anti-inflammatory cream under the trade name Acheflan. The company initiated product development after Brazil reformed its patent law in 1996 and later filed for Brazilian and international patent protection.
The CIEC report concludes that two changes are behind Brazil's bio-medical innovation revolution. First, the Brazilian public sector has made substantial investment into university and public laboratory research and into specific bio-diversity-based projects, thereby establishing the potential for bio-medical technology innovation. Secondly, in December 2004, the Brazilian government passed a law that encourages public-private R&D partnerships by specifying and clarifying intellectual property rights.
The Creative and Innovative Economy Center conducts research and educational activities regarding the market, business strategy, legal, institutional, globalization, and localization characteristics of creativity and innovation in the world economy. Programs are conducted at The George Washington University in Washington, D.C., in Europe at the Munich Intellectual Property Law Center and in Geneva, and in developing countries around the world.
Accredited by the American Bar Association and a charter member of the Association of American Law Schools, The George Washington University Law School enrolls approximately 1,800 students each year. GW Law has been a leader in intellectual property education and scholarship for more than a hundred years and today has one of the most highly regarded academic specialty programs in the United States.
For more information about CIEC visit www.law.gwu.edu/ciec.
For more news about GW, visit the GW News Center at www.gwnewscenter.org.
- GW -